Dr Bo Kara | Vice President Process Development
Evox Therapeutics

Dr Bo Kara, Vice President Process Development, Evox Therapeutics

Bo Kara heads up the Process Development team for Advanced Therapy Delivery at GSK. He has over 25 years’ experience in designing research and development programmes to develop scaleable and validatable manufacturing processes for recombinant protein products. He has published widely and is primary inventor on a range of process/expression patents. He has developed a keen understanding of the technical, regulatory and commercial issues faced at each stage of the development of manufacturing processes for biopharmaceuticals.
Bo Kara will be discussing manufacturing ex-vivo cell & gene therapy for rare disease and oncology applications, expression and manufacturing platforms for lentivirus production and CAR-T, upscaling to improve patient access and attepting to answer the question what does the future hold for this area of manufacturing?


Conference Day 1 - Tuesday 31st March 2020 @ 17:20

Panel discussion: process development for next generation therapeutics

Conference Day 2 - Wednesday 1st April 2020 @ 11:20

Engineered Exosome Therapeutics – Development and Manufacturing

last published: 06/Dec/19 09:35 GMT

back to speakers